stockportfolio.pro
Neogen Corporation (NEOG)
Healthcare · Medical Devices · NasdaqGS
Neogen Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.27M | $358.28M | $397.93M | $414.19M | $418.17M | $468.46M | $527.16M | $822.45M | $924.22M | $894.66M |
| Gross profit | $153.06M | $168.92M | $186.27M | $191.92M | $196.28M | $215.06M | $243.01M | $405.95M | $463.90M | $421.38M |
| Net income | $36.56M | $43.79M | $63.15M | $60.18M | $59.48M | $60.88M | $48.31M | $-22.87M | $-9.42M | $-1.09B |
| Net margin | 11.4% | 12.2% | 15.9% | 14.5% | 14.2% | 13.0% | 9.2% | -2.8% | -1.0% | -122.1% |
Source: Neogen Corporation SEC filings (10-K). 16 years of history available in the interactive view.
Explore 16 years of Neogen Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track NEOG in your portfolio →
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Neogen Corporation — frequently asked questions
What is Neogen Corporation's revenue?
Neogen Corporation (NEOG) reported revenue of $894.66M for fiscal year 2025, down 3.2% from the prior year, according to its SEC filings.
Is Neogen Corporation profitable?
No — NEOG reported a net loss of $-1.09B in fiscal 2025.
What is NEOG's P/E ratio?
Neogen Corporation trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Neogen Corporation growing?
NEOG's revenue grew at roughly 16.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Neogen Corporation's official SEC filings (10-K and 10-Q), covering 16 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.